REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...
REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...
REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>REP11</strong>/<strong>PR</strong> 15<br />
ESTABLISHMENT OF THE <strong>PR</strong>IORITY LISTS OF PESTICIDES (Agenda Item 12a) 19<br />
138. The Delegation of Australia, as Chair of the in-session Working Group on Priorities introduced the report of the working group.<br />
The Chair mentioned the addition of new information on registration status, expected residues and residue trials available in order to<br />
help setting priorities. He also mentioned new appendixes to the schedule, mentioning compounds which are no longer supported by<br />
industry (Table 5) and commodities which are no longer supported by industry (Table 6). These two appendices will increase the<br />
transparency and will allow member states to be prepared to support compounds and commodities no longer supported by industry.<br />
Periodic Re-evaluation<br />
139. Procymidone (136) and Vinclozolin (159) are no longer supported by industry and member countries. Therefore, the<br />
Committee decided that all CXLs for these 2 compounds should be revoked.<br />
140. After some discussions and adjustments, the Committee agreed on the Priority List for 2012 provided as Appendix XI.<br />
Scheduling of chemicals<br />
141. The Committee was informed that 12 chemicals had been nominated for inclusion on the schedule for new compounds and<br />
periodic re-evaluation for 2012. The Chair listed the seven new chemical evaluations (ametoctradin, chlorfenapyr, dinotefuran,<br />
fluxapyroxad, MCPA, picoxystrobin, sedaxane), and the five chemicals listed for periodic re-evaluation (bentazone, cycloxydim,<br />
dichlorvos, fenvalerate, glufosinate-ammonium). The delegations of Thailand and the United States of America confirmed their<br />
support to the re-evaluation of fenvalerate which is not longer supported by the primary manufacturer.<br />
142. The Committee nominated 21 chemicals for follow-up evaluations namely fenbuconazole for consideration of the<br />
establishment of an ARfD and 20 substances for MRLs in additional commodities (buprofezin, captan, carbofuran, chlorothalonil,<br />
chlorpyrifos-methyl, cyfluthrin, cyproconazole, cyromazine, 2,4-D, dithiocarbamates-mancozeb, fludioxynil, flupyram, imidacloprid,<br />
methoxyfenozide, oxamyl, phorate, spinetoram, thiacloprid, thiamethoxate and trifloxystrobin).<br />
143. The Committee was informed that this number of compounds exceed the possibilities of the JM<strong>PR</strong> regarding the<br />
establishment of MRLs. It was therefore proposed by Croplife to postpone the periodic re-evaluation of residue limits for bentazone<br />
until 2013 but to keep this compound for toxicological re-evaluation in 2012. The Committee was advised that with these<br />
adjustments, the 2012 schedule had reached its quota and technically could not accept any further nominations.<br />
144. The Committee noted the chemicals listed for new evaluation and follow-up evaluation for the years 2013 to 2018 and that for<br />
2013, 12 new compounds are listed for evaluation and 13 compounds are listed for periodic re-evaluation. This is clearly exceeding<br />
the capacities of the JM<strong>PR</strong>. Moreover, the Committee also noted that more than 40 substances are already on the list for periodic reevaluation<br />
following the rule of 15 years. The Committee agreed to give the mandate to the Working Group on Priorities to propose a<br />
list of 2 to 3 chemicals every year, from the full list of substances candidate for periodic re-evaluation, based on their potential higher<br />
concern regarding public health.<br />
145. The Chair indicated that the work of the EWG for 2012 would commence in August with the broadcast email to all member<br />
countries and observers. In that correspondence, the Chair will highlight chemicals for which there is no manufacturer support and<br />
chemicals for which commodity listings are required. The Chair will also propose a re-ordering of the list of chemicals candidate for<br />
periodic re-evaluation based of the potential health concerns. The Committee agreed to reconvene the electronic working group<br />
chaired by Australia for 2012.<br />
CONSIDERATION OF THE STATUS OF CODEX MRLs for LINDANE (Agenda Item 12b) 20<br />
146. The Delegation of Australia, as Chair of the on in-session Working Group on Priorities introduced this item vis-à-vis the<br />
relation between the status of Codex MRLs for lindane and the Priority List as per the eligibility of this compound for re-evaluation in<br />
the future.<br />
147. The Committee noted that lindane is currently listed in Annex A of the Stockholm Convention by which Parties must take<br />
measures to eliminate the production and use of the chemicals listed under this Annex. The Committee considered the possible<br />
replacement of the existing lindane MRLs with EMRLs based on the different options provided for in the discussion paper.<br />
19 CX/<strong>PR</strong> 11/14/13 & CX/<strong>PR</strong> 11/14/13-Add.1. CX/<strong>PR</strong> 11/14/13-Add.2 (comments from Brazil, Canada and Uruguay). Additional comments from Kenya (CRD 5);<br />
EU (CRD 14); Mali (CRD 21); Australia (CRD 26); and the Democratic People’s Republic of Korea (CRD 27).<br />
20 CX/<strong>PR</strong> 11/43/14. Comments from Kenya (CRD 5) and Croplife (CRD 7).